Moleculin Biotech (MBRX) Institutional Ownership $0.97 -0.01 (-1.01%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$0.97 0.00 (0.00%) As of 05/21/2025 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Moleculin Biotech (NASDAQ:MBRX)CurrentInstitutional OwnershipPercentage15.52%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$930.86KNumber ofInstitutional Sellers(last 12 months)0 Get MBRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Moleculin Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MBRX Institutional Buying and Selling by Quarter Moleculin Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/15/2025 Armistice Capital LLC1,250,000$1.22M0.0%+293.6%8.929% 8/15/2024 Armistice Capital LLC156,000$549K0.0%+5.1%6.747% 2/13/2024 Armistice Capital LLC3,207,417$2.75M0.0%N/A9.600% 1/17/2024 Atticus Wealth Management LLC50,001$43K0.0%N/A0.168% 5/15/2023 Sio Capital Management LLC1,010,956$971K0.5%-2.5%3.407% 7/25/2022 Walker Asset Management LLC20,708$32K0.0%N/A0.072% 4/20/2022 Sigma Planning Corp57,500$102K0.0%+33.7%0.201% 2/2/2022 Sigma Planning Corp43,000$80K0.0%N/A0.150% 11/9/2021BlackRock Inc.270,402$812K0.0%-2.5%0.947% 9/17/2021 Virtu Financial LLC25,302$93K0.0%N/A0.089% 8/16/2021 Occudo Quantitative Strategies LP29,188$107K0.0%+31.7%0.102% 8/16/2021 State Street Corp59,900$220K0.0%N/A0.210% 8/13/2021 Geode Capital Management LLC237,586$871K0.0%+35.9%0.835% 8/13/2021 Vanguard Group Inc.1,047,529$3.84M0.0%+123.6%3.683% 8/12/2021 XTX Topco Ltd32,997$121K0.0%N/A0.116% 8/5/2021 GSA Capital Partners LLP31,120$114K0.0%N/A0.109% 5/21/2021 Citadel Advisors LLC13,843$56K0.0%N/A0.049% 5/19/2021 Squarepoint Ops LLC28,904$118K0.0%+134.2%0.102% 5/18/2021 Cubist Systematic Strategies LLC26,624$109K0.0%N/A0.094% 5/18/2021 Citadel Advisors LLC13,843$56K0.0%N/A0.049% 5/14/2021 Occudo Quantitative Strategies LP22,158$90K0.0%N/A0.078% 5/12/2021 Northern Trust Corp50,731$207K0.0%-43.1%0.178% 5/12/2021 Geode Capital Management LLC174,822$713K0.0%-40.6%0.615% 5/7/2021BlackRock Inc.239,326$977K0.0%+449.7%0.841% (Data available from 1/1/2016 forward) MBRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MBRX shares? During the previous two years, the following institutional investors and hedge funds held shares of Moleculin Biotech shares: Armistice Capital LLC ($1.22M), Atticus Wealth Management LLC ($43K).Learn more on MBRX's institutional investors. What percentage of Moleculin Biotech stock is owned by institutional investors? 15.52% of Moleculin Biotech stock is owned by institutional investors. Learn more on MBRX's institutional investor holdings. Which institutional investors have been buying Moleculin Biotech stock? The following institutional investors have purchased Moleculin Biotech stock in the last 24 months: Armistice Capital LLC ($4.15M), and Atticus Wealth Management LLC ($50.00K). How much institutional buying is happening at Moleculin Biotech? Institutional investors have bought a total of 4,197,337 shares in the last 24 months. This purchase volume represents approximately $42.87M in transactions. Related Companies ASRT Institutional Ownership PDSB Institutional Ownership RPTX Institutional Ownership IMMX Institutional Ownership MGX Institutional Ownership ADVM Institutional Ownership GANX Institutional Ownership SKYE Institutional Ownership DTIL Institutional Ownership IKNA Institutional Ownership This page (NASDAQ:MBRX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street see...Porter & Company | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moleculin Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moleculin Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MBRX Stock Free MBRX Stock Alerts